Browse key industry insights from the report “Fertility Testing Devices Market Size,
Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, France, Italy,
UK, Spain, Russia, China, India, Japan, South Korea, Australia, New Zealand,
Singapore, Argentina, Brazil, Mexico, South Africa, Saudi Arabia), Application
Development Potential, Price Trends, Competitive Market Share & Forecast, 2017
– 2024” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/fertility-testing-devices-market
OTC based or non-prescription segment accounted for major share due to easily
available ovulation and fertility monitors on the websites, rising supporting initiatives
undertaken by companies to generate awareness amongst the population concerning
advancement in products and its availability in various cities. The aforementioned
factors increase the preferences, accessibility, and confidentiality of the test resulting in
rapid diagnosis that stimulates the product adoption rate.
U.S. accounted for largest revenue share of 2016 attributed to the increasing prevalence
of the PCOS, growing first-time pregnancy age, and declining fertility rates that demands
for high adoption of the fertility testing devices market products. Additionally, the
associated benefits of the devices provided through the fertility awareness methods
(FAM), and ovulation monitors boost the industry progress. India and China will
witness lucrative business growth opportunities owing to the increasing funding in the
development of ovulation and fertility monitors, intensifying focus of domestic as well
as international companies for business expansion. Moreover, decrease in fertility rates
and lifestyle disorders are the factors propelling the demand.
Some of the business players include Fertility Focus, Fairhaven Health, Church &
Dwight, Geratherm Medical, HiLin Life Products, Babystart, Taidoc Technology, Quidel,
AccuQuik, Alere, bioMérieux, Abbott Laboratories, Prestige Brands Holdings, and
Procter & Gamble. The business players emphasis on strategic acquisitions, partnership,
and alliances for growth in company development. For instance, in April 2014, the
Prestige Brands, announced agreement of acquiring Insight Pharmaceuticals that
markets and distributes feminine care as well as OTC healthcare products. This
acquisition will provide the company with increase in the business revenue and
strengthen its product portfolio.
2 | Page